A Multiparametric MRI-based Model for decoding Extraprostatic Extension in Prostate Cancer via Habitat-guided Radiomics and Clinical Integration
- PMID: 40813162
- DOI: 10.1016/j.acra.2025.07.056
A Multiparametric MRI-based Model for decoding Extraprostatic Extension in Prostate Cancer via Habitat-guided Radiomics and Clinical Integration
Abstract
Rationale and objectives: Develop and validate a multiparametric MRI-based integrative model that combines intratumoral microenvironmental heterogeneity, peritumoral radiomic features, and clinicopathological variables for the noninvasive preoperative prediction of extraprostatic extension (EPE) in prostate cancer, aiming to support surgical decision-making and reduce postoperative biochemical recurrence.
Methods: MRI and clinicopathological data from 590 prostate cancer (PCa) patients across four centers (August 2013-September 2023) were retrospectively collected and divided into a training cohort (n = 249), internal validation cohort (n = 106), and two external test cohorts (n₁ = 199, n₂ = 36). Radiomic and habitat features were extracted from T2WI, DWI, ADC, and DCE MRI sequences. Six models were constructed: Clinical, Radiomics, Peri2mm, Peri4mm, Peri6mm, and Habitat. These were subsequently integrated into a fusion model (Habitat + Peri6mm + Clinical). Model performance was evaluated using ROC analysis, DCA, calibration curve, DeLong's test, nomogram and SHAP interpretation.
Results: The habitat model outperformed all unimodal models, achieving AUCs of 0.978 (training), 0.893 (validation), 0.832 and 0.836 (external test sets). Among radiomics-based models, the Peri6mm model showed the highest performance, with AUCs ranging from 0.949 to 0.752. The fusion model achieved the best overall predictive performance, with AUCs of 0.982 (training), 0.921 (validation), and 0.853 and 0.839 (external).
Conclusion: Habitat and peritumoral radiomic features were independently predictive of EPE. The fusion model, integrating clinical, peritumoral, and habitat-derived features, further enhanced preoperative predictive accuracy.
Keywords: Extraprostatic extension(EPE); Intratumoral heterogeneity; Magnetic resonance imaging (MRI); Peritumoral radiomics; Prostatic cancer.
Copyright © 2025 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Reports a relationship with that includes:. Has patent pending to. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
An Integrative Clinical and Intra- and Peritumoral MRI Radiomics Nomogram for the Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer.Acad Radiol. 2025 Jul;32(7):3989-4001. doi: 10.1016/j.acra.2025.02.019. Epub 2025 Mar 4. Acad Radiol. 2025. PMID: 40044546
-
The value of multiparametric MRI-based combined intratumoral and peritumoral radiomics in differentiating luminal and non-luminal molecular subtypes of breast cancer: a multicenter study.Gland Surg. 2025 Jul 31;14(7):1195-1212. doi: 10.21037/gs-2025-83. Epub 2025 Jul 28. Gland Surg. 2025. PMID: 40771390 Free PMC article.
-
Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study.Quant Imaging Med Surg. 2024 Dec 5;14(12):8211-8226. doi: 10.21037/qims-24-558. Epub 2024 Oct 31. Quant Imaging Med Surg. 2024. PMID: 39698668 Free PMC article.
-
MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.Acad Radiol. 2024 Mar;31(3):763-787. doi: 10.1016/j.acra.2023.10.010. Epub 2023 Nov 2. Acad Radiol. 2024. PMID: 37925343
-
Multiparametric radiomic analysis of MRI for predicting satellite nodules and recurrence-free survival in patients with hepatocellular carcinoma.Magn Reson Imaging. 2025 Oct;122:110450. doi: 10.1016/j.mri.2025.110450. Epub 2025 Jun 16. Magn Reson Imaging. 2025. PMID: 40532770 Review.
LinkOut - more resources
Full Text Sources